1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Wang, Y. Henz, M.E. Gallagher, N.L.F. Chai, S. Yan, L.Z. Gibbs, A.C. Stiles, M.E. Wishart, D.S. Vederas, J.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 38 15438 15447 10.1021/bi991351x 10569926 Solution structure of carnobacteriocin B2 and implications for structure-activity relationships among type IIa bacteriocins from lactic acid bacteria. 1999 10.2210/pdb1cw5/pdb pdb_00001cw5 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4974.490 TYPE IIA BACTERIOCIN CARNOBACTERIOCIN B2 1 nat polymer no no VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Carnobacterium sample 2751 Carnobacterium maltaromaticum database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 1999-09-07 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession RCSB Y RCSB 1999-08-25 REL REL THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES. THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY. STRUCTURES WITH ACCEPTABLE COVALENT GEOMETRY,STRUCTURES WITH FAVORABLE NON- BOND ENERGY,STRUCTURES WITH THE LEAST RESTRAINT VIOLATIONS,STRUCTURES WITH THE LOWEST ENERGY 30 20 2D NOESY 0 2.8 AMBIENT 298 K THE STRUCTURES ARE BASED ON A TOTAL OF 319 PROTON DISTANCE RESTRAINTS, 88 DIHEDRAL ANGLE RESTRAINTS, 8 3JHNHA COUPLING CONSTANT RESTRAINTS, AND 163 PROTON CHEMICAL SHIFT RESTRAINTS. simulated annealing 6 closest to the average 5.0 MG CARNOBACTERIOCIN B2 IS DISOLVED IN 700 UL OF TFE-D3/H2O, 90%:10% V/V, PH 2.8. BRUNGER structure solution X-PLOR 3.85 VARIAN processing VNMR 5.1 BRUNGER refinement X-PLOR 3.85 600 Varian UNITY 500 Varian UNITY VAL 1 n 1 VAL 1 A ASN 2 n 2 ASN 2 A TYR 3 n 3 TYR 3 A GLY 4 n 4 GLY 4 A ASN 5 n 5 ASN 5 A GLY 6 n 6 GLY 6 A VAL 7 n 7 VAL 7 A SER 8 n 8 SER 8 A CYS 9 n 9 CYS 9 A SER 10 n 10 SER 10 A LYS 11 n 11 LYS 11 A THR 12 n 12 THR 12 A LYS 13 n 13 LYS 13 A CYS 14 n 14 CYS 14 A SER 15 n 15 SER 15 A VAL 16 n 16 VAL 16 A ASN 17 n 17 ASN 17 A TRP 18 n 18 TRP 18 A GLY 19 n 19 GLY 19 A GLN 20 n 20 GLN 20 A ALA 21 n 21 ALA 21 A PHE 22 n 22 PHE 22 A GLN 23 n 23 GLN 23 A GLU 24 n 24 GLU 24 A ARG 25 n 25 ARG 25 A TYR 26 n 26 TYR 26 A THR 27 n 27 THR 27 A ALA 28 n 28 ALA 28 A GLY 29 n 29 GLY 29 A ILE 30 n 30 ILE 30 A ASN 31 n 31 ASN 31 A SER 32 n 32 SER 32 A PHE 33 n 33 PHE 33 A VAL 34 n 34 VAL 34 A SER 35 n 35 SER 35 A GLY 36 n 36 GLY 36 A VAL 37 n 37 VAL 37 A ALA 38 n 38 ALA 38 A SER 39 n 39 SER 39 A GLY 40 n 40 GLY 40 A ALA 41 n 41 ALA 41 A GLY 42 n 42 GLY 42 A SER 43 n 43 SER 43 A ILE 44 n 44 ILE 44 A GLY 45 n 45 GLY 45 A ARG 46 n 46 ARG 46 A ARG 47 n 47 ARG 47 A PRO 48 n 48 PRO 48 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A HG22 H VAL ASN 1 2 0.64 1 A A CG2 H VAL ASN 1 2 1.34 1 A A O H THR ASN 27 31 1.58 4 A A HG21 H VAL ASN 1 2 0.55 4 A A HG23 CD2 VAL TYR 1 3 0.96 4 A A HG23 CE2 VAL TYR 1 3 1.01 4 A A HG13 HG13 VAL VAL 1 7 1.27 4 A A HG12 HD2 VAL TYR 1 3 1.32 4 A A HG21 N VAL ASN 1 2 1.51 4 A A CG2 H VAL ASN 1 2 1.57 4 A A CG2 CE2 VAL TYR 1 3 1.67 4 A A CG2 CD2 VAL TYR 1 3 2.00 4 A A CG1 CG1 VAL VAL 1 7 2.16 5 A A O HG1 GLN THR 23 27 1.47 6 A A O H THR ASN 27 31 1.54 13 A A HG12 H VAL ASN 1 2 1.02 13 A A O HG ALA SER 28 32 1.53 14 A A HG21 H VAL ASN 1 2 1.32 15 A A O HG1 GLN THR 23 27 1.59 16 A A HG13 H VAL ASN 1 2 1.28 16 A A O HD2 PHE TYR 22 26 1.51 16 A A O HG ALA SER 28 32 1.58 17 A A HG23 H VAL ASN 1 2 0.78 17 A A HG22 CE2 VAL TYR 1 3 0.99 17 A A HG22 CD2 VAL TYR 1 3 1.13 17 A A HG22 HE2 VAL TYR 1 3 1.33 17 A A CG2 CE2 VAL TYR 1 3 1.82 17 A A CG2 CD2 VAL TYR 1 3 2.10 18 A A O HG1 GLN THR 23 27 1.41 19 A A HG11 HB2 VAL ASN 1 5 0.50 19 A A HG21 H VAL ASN 1 2 0.74 19 A A HG23 H VAL ASN 1 5 1.29 19 A A HG23 N VAL ASN 1 5 1.31 19 A A CG1 HB2 VAL ASN 1 5 1.37 19 A A O HG1 GLN THR 23 27 1.40 19 A A HG21 N VAL ASN 1 2 1.53 19 A A HG11 CB VAL ASN 1 5 1.55 20 A A HG13 H VAL ASN 1 2 0.99 20 A A HG13 N VAL ASN 1 2 1.52 20 A A O HD2 PHE TYR 22 26 1.54 1 A ASN 5 -162.63 29.64 1 A LYS 11 45.21 163.45 1 A THR 12 -90.05 58.82 1 A LYS 13 -158.25 -90.38 1 A CYS 14 75.27 93.71 1 A SER 15 -162.20 -47.87 1 A VAL 16 -164.69 117.09 1 A ALA 41 179.04 82.70 1 A ILE 44 -178.21 69.24 1 A ARG 46 -100.42 54.97 2 A TYR 3 68.90 86.63 2 A ASN 5 -162.74 -64.82 2 A VAL 7 62.98 -64.82 2 A SER 8 48.48 92.10 2 A CYS 9 54.55 89.05 2 A THR 12 -88.95 -84.16 2 A LYS 13 -158.37 38.63 2 A VAL 16 -163.65 99.90 2 A ALA 21 -56.94 -70.04 2 A ALA 41 65.91 74.89 2 A ARG 46 66.13 118.76 3 A ASN 2 -161.10 -45.12 3 A SER 10 -163.59 92.28 3 A LYS 13 68.60 -69.38 3 A SER 15 62.96 176.39 3 A VAL 16 -163.88 111.13 3 A TRP 18 49.13 27.32 3 A ALA 41 178.95 83.63 3 A SER 43 -67.22 -75.07 4 A ASN 2 -160.44 28.09 4 A ASN 5 -162.33 39.34 4 A CYS 9 -176.74 131.37 4 A LYS 11 48.08 20.42 4 A LYS 13 80.25 -6.65 4 A CYS 14 69.10 -70.35 4 A SER 15 -57.34 -167.51 4 A VAL 16 81.15 -70.61 4 A ASN 17 173.36 -33.31 4 A TRP 18 -39.18 -33.99 4 A ALA 41 83.37 -9.55 4 A SER 43 -104.03 -65.31 4 A ILE 44 -155.62 33.56 4 A ARG 46 -173.55 39.36 4 A ARG 47 42.24 85.67 5 A ASN 2 71.11 -69.04 5 A ASN 5 -162.47 -42.42 5 A SER 8 60.81 95.34 5 A LYS 13 -158.50 -68.64 5 A CYS 14 74.31 66.25 5 A ASN 17 63.36 -63.36 5 A SER 43 -173.06 77.05 5 A ILE 44 -154.58 59.87 5 A ARG 46 58.76 -173.00 5 A ARG 47 44.90 101.17 6 A ASN 2 -160.78 69.50 6 A ASN 5 79.61 71.60 6 A SER 8 -178.87 68.67 6 A LYS 11 77.63 129.24 6 A THR 12 60.00 176.83 6 A VAL 16 81.01 90.53 6 A ILE 44 72.64 79.87 6 A ARG 46 -160.34 98.75 7 A TYR 3 -157.30 38.41 7 A ASN 5 -161.55 -49.19 7 A SER 10 -93.17 -68.84 7 A THR 12 64.60 -65.11 7 A CYS 14 -166.56 42.41 7 A SER 43 62.83 66.43 7 A ILE 44 -106.12 43.62 7 A ARG 47 -140.01 55.02 8 A SER 8 64.40 101.02 8 A SER 15 -75.26 -149.53 8 A VAL 16 -164.24 108.98 8 A ILE 44 -166.83 60.27 8 A ARG 46 -179.81 99.34 9 A LYS 11 81.53 -1.72 9 A SER 15 61.50 -177.56 9 A VAL 16 -162.32 113.61 9 A ALA 41 -145.35 -59.35 9 A ILE 44 -152.18 63.77 10 A CYS 9 -166.59 82.59 10 A SER 10 -72.14 -163.62 10 A CYS 14 167.28 -46.43 10 A VAL 16 -164.50 86.98 10 A ALA 21 -60.29 -71.55 10 A ALA 41 -178.88 -71.42 10 A SER 43 64.83 71.19 10 A ARG 46 62.22 95.89 11 A ASN 5 -161.23 53.69 11 A VAL 7 -150.33 37.40 11 A SER 8 -176.93 40.43 11 A SER 10 -74.67 -73.36 11 A ALA 41 -157.29 -72.08 12 A ASN 2 -160.87 26.65 12 A ASN 5 -162.59 58.30 12 A VAL 7 51.12 88.30 12 A SER 10 -172.73 -39.20 12 A SER 15 -173.61 -174.22 12 A VAL 16 -164.99 -43.29 12 A ASN 17 -64.36 91.93 12 A SER 43 -177.36 74.19 12 A ARG 47 54.89 94.26 13 A ASN 2 78.44 -58.30 13 A TYR 3 69.65 -75.00 13 A ASN 5 -162.76 32.97 13 A SER 8 -143.65 -146.88 13 A THR 12 -150.78 69.02 13 A LYS 13 74.61 170.15 13 A ASN 17 -63.83 -162.77 13 A SER 43 178.26 62.86 13 A ARG 46 61.60 69.05 14 A ASN 2 76.16 -60.06 14 A TYR 3 64.59 109.34 14 A ASN 5 -163.26 -54.79 14 A SER 8 51.30 109.68 14 A LYS 13 -159.13 39.41 14 A VAL 16 -164.27 33.73 14 A ASN 17 67.37 -71.74 14 A ILE 44 -168.52 -40.79 14 A ARG 46 -121.07 -69.17 15 A ASN 5 -162.67 -67.97 15 A SER 8 61.31 126.76 15 A CYS 9 -147.52 -88.19 15 A SER 10 37.24 67.20 15 A LYS 11 -162.06 -21.11 15 A THR 12 -150.86 -21.07 15 A CYS 14 74.22 137.06 15 A ALA 21 -59.02 -70.02 15 A SER 43 -171.29 -51.52 15 A ILE 44 -150.56 -79.99 16 A ASN 2 -162.13 -160.13 16 A TYR 3 61.25 163.66 16 A ASN 5 73.38 60.51 16 A SER 8 -81.22 -148.93 16 A LYS 11 -161.45 -77.74 16 A CYS 14 -161.41 -74.50 16 A VAL 16 77.45 131.82 16 A ARG 47 56.07 89.63 17 A ASN 2 -160.87 21.42 17 A TYR 3 -80.69 -153.28 17 A ASN 5 80.83 86.05 17 A VAL 7 60.58 118.30 17 A CYS 9 66.92 -54.92 17 A LYS 11 78.26 -59.67 17 A LYS 13 -159.17 -55.09 17 A VAL 16 -163.59 100.42 17 A ALA 21 -63.33 -71.48 17 A ARG 47 35.36 105.13 18 A ASN 2 -161.36 91.80 18 A SER 10 54.23 -84.24 18 A LYS 11 -161.66 -24.11 18 A LYS 13 47.51 -173.78 18 A CYS 14 -133.97 -158.48 19 A ASN 2 -163.10 -46.43 19 A ASN 5 74.89 63.19 19 A VAL 7 -149.68 -42.76 19 A SER 8 178.20 130.51 19 A THR 12 58.36 16.41 19 A LYS 13 -160.13 -39.35 19 A SER 15 -173.68 137.91 19 A VAL 16 -164.80 116.95 19 A ALA 41 -141.80 -77.37 19 A SER 43 -155.47 38.75 20 A ASN 2 -161.76 -5.01 20 A ASN 5 -162.28 63.05 20 A CYS 9 -171.77 101.03 20 A SER 10 -78.52 -102.23 20 A LYS 11 -162.70 37.71 20 A THR 12 -151.09 -77.66 20 A CYS 14 57.89 170.71 20 A TRP 18 -89.17 36.49 20 A ILE 44 -133.78 -69.38 20 A ARG 46 68.83 -65.01 20 A ARG 47 57.36 73.22 SOLUTION STRUCTURE OF CARNOBACTERIOCIN B2 1 N N A ASN 17 A ASN 17 HELX_P A GLY 42 A GLY 42 1 1 26 disulf 2.031 A CYS 9 A SG CYS 9 1_555 A CYS 14 A SG CYS 14 1_555 TOXIN ANTIMICROBIAL PEPTIDE, HELIX, BACTERIOCIN, TOXIN CBB2_CARPI UNP 1 P38580 19 66 1CW5 1 48 P38580 A 1 1 48 1 P 1